Twist Bioscience (TWST) Receivables - Other (2018 - 2026)

Twist Bioscience (TWST) has reported Receivables - Other for 8 consecutive years, with $2000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Other changed N/A year-over-year to $2000.0 in Q2 2026; TTM through Jun 2026 was $2000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $290000.0, changed N/A from the prior year.
• Receivables - Other was $2000.0 for Q2 2026 at Twist Bioscience, down from $17.1 million in the prior quarter.
• Over five years, Receivables - Other peaked at $17.1 million in Q1 2026 and troughed at $2000.0 in Q2 2026.
• A 4-year average of $5.5 million and a median of $5.3 million in 2022 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other soared 107.17% in 2022 and dropped 16.39% in 2023, its largest moves.
• Over 4 years, Receivables - Other stood at $5.3 million in 2022, then climbed by 6.0% to $5.6 million in 2023, then sank by 94.79% to $290000.0 in 2025, then sank by 99.31% to $2000.0 in 2026.
• The last three Receivables - Other figures came in at $2000.0 (Q2 2026), $17.1 million (Q1 2026), and $290000.0 (Q3 2025), per Business Quant data.